Minuscule particles with the ability to cross hard-to-penetrate barriers can be loaded with drug treatments to target intractable diseases.

Transitioning from multiple daily injections to a tubeless automated insulin delivery (AID) system significantly improves HbA1c in T1D.

In response to evolving regulatory expectations, the industry is moving toward integrated, risk-based, and transparent ...

Nephrodite’s technology improves the lives of dialysis patients. OrthoPreserve’s device addresses challenges faced by those ...